Validity of Colposcopy in the Diagnosis of Early Cervical Neoplasia. Dr. Olaniyan Olayinka Babafemi

Similar documents
Colposcopy. Attila L Major, MD, PhD

Understanding Your Pap Test Results

Over-diagnoses in Cytopathology: Is histology the gold standard?

Appropriate Use of Cytology and HPV Testing in the New Cervical Cancer Screening Guidelines

Original Policy Date

Management Algorithms for Abnormal Cervical Cytology and Colposcopy

Case Based Problems. Recommended Guidelines. Workshop: Case Management of Abnormal Pap Smears and Colposcopies. Disclosure

Faculty Pap Smear Guidelines: Family Planning Update 2008 Part Two

Your Colposcopy Visit

What is a Pap smear?

Histopathology: Cervical HPV and neoplasia

Cervical Precancer: Evaluation and Management

BC Cancer Cervix Screening 2015 Program Results. February 2018

Done by khozama jehad. Neoplasia of the cervix

Cervical Screening for Dysplasia and Cancer in Patients with HIV

Lessons From Cases of Screened Women Who Developed Cervical Carcinoma

Telemedicine enables doctors in rural areas. Remote diagnosis of cervical neoplasia: 2 types of telecolposcopy compared with cervicography

Clinical Usefulness of Cervicogram as a Primary Screening Test for Cervical Neoplasia

Colposcopic Evaluation Of Patients With Abnormal Cervical Cytology And Its Histopathological Corelation An Original Article

Management of Abnormal Cervical Cytology and Histology

Clinical Guidance: Recommended Best Practices for Delivery of Colposcopy Services in Ontario Best Practice Pathway Summary

Adjunctive colposcopy technologies for examination of the uterine cervix DySIS, LuViva Advanced Cervical Scan and Niris Imaging System

CERVICAL CANCER SCREENING IN BOTSWANA: A ROLE FOR TELEMEDICINE A. STATEMENT OF HYPOTHESIS AND SPECIFIC AIMS

Name of Policy: Speculoscopy

Colposcopic Proficiency-Disease Spectrum in a Single Family Practice Colposcopists Clinic

ASCCP 2013 Guidelines for Managing Abnormal Cervical Cancer Screening Tests

Clinical Practice Guidelines June 2013

Becoming a colposcopist: Colposcope case studies

Patients referred to a colposcopy clinic will often have

Associate Professor of Gyn. & Obs., Department of Gynecology and Obstetrics, Tehran University of Medical Sciences, Iran.

Partha Basu M.D. Screening Group/ Early Detection & Prevention Section

Cost-Effectiveness Analysis of Diagnosis and Management of Cervical Squamous Intraepithelial Lesions

Gynecologic Cytology-Histology Correlation Guideline

Cytology/Biopsy/Leep Gynecologic Correlation: Practical Considerations and Approaches.

Cervical Cancer Screening Update. Melissa Hartman, DO Women s Health

Streamlining Protocols-From Strategy to Implementation. Doreen Ramogola-Masire Botswana UPenn Partnership June 2014

Making Sense of Cervical Cancer Screening

Cytology Update M Laing QEUH

Pap plus HPV every 3 years with screening stopped at 65, 75 and 100 years; Pap plus HPV every 2 years with screening stopped at 65, 75 and 100 years.

Cytology Report Format

Study Number: Title: Rationale: Phase: Study Period Study Design: Centres: Indication Treatment: Objectives: Primary Outcome/Efficacy Variable:

Dysplasia: layer of the cervical CIN. Intraepithelial Neoplasia. p16 immunostaining. 1, Cervical. Higher-risk, requires CIN.

Multimodal Spectroscopic Imaging of the Cervix for Triaging Patients to Colposcopy

The Pap Smear Test. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series

Eradicating Mortality from Cervical Cancer

What is a Pap Smear and What do the results mean? Maria E Daheri RN Cervical Nurse Case Harris Health System

EFC and European Standards for Colposcopic Evaluation

Cervical Cancer Screening. David Quinlan December 2013

Cervical Cancer Screening Guidelines Update

The routine use of ZedScan within one colposcopy service in England. MC Macdonald, R Lyon, JE Palmer, JA Tidy

Cuid d Fheidhmeannacht na Seirbhíse Sláinte. Part of the Health Service Executive. CS/PR/PM-20 Rev 2 ISBN Programme Report 2014/2015

Comparison of Visual Inspection with Acetic Acid and Pap Smear in Detecting Premalignant Lesions of Cervix

Screening for the Precursors of Cervical Cancer in the Era of HPV Vaccination. Dr Stella Heley Senior Liaison Physician Victorian Cytology Service

!"#$%&'(#)*$+&,$-&.#,$/#0()1-$ ),1')$2(%&,2#,%$%(0'#$34567$

Chapter 10: Pap Test Results

Details of HPV-based Cervical Cancer Screening in Turkey

Screening for Cervical Cancer: Demystifying the Guidelines DR. NEERJA SHARMA

Abnormal Spectroscopy Scans May Presage Persistent or Progressive Cervical Dysplasia

Clinical Policy Title: Fluorescence in situ hybridization for cervical cancer screening

PRE TEST CERVICAL SCREENING MANAGEMENT COLPOSCOPY PATHOLOGIC DIAGNOSIS AND TREATMENT

Human Papillomaviruses and Cancer: Questions and Answers. Key Points. 1. What are human papillomaviruses, and how are they transmitted?

Woo Dae Kang, Ho Sun Choi, Seok Mo Kim

Cervical Cancer Screening for the Primary Care Physician for Average Risk Individuals Clinical Practice Guidelines. June 2013

I have no financial interests in any product I will discuss today.

Cervical Cancer Prevention in the 21 st Century Changing Paradigms

CERVICAL INTRAEPITHELIAL NEOPLASIA (CIN)

Acceptable predictive accuracy of histopathology results by colposcopy done by Gynecology residents using Reid index

Biomed Environ Sci, 2015; 28(1): 80-84

The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial

Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force

Study population The study population comprised women residing in Keelung, northern Taiwan.

The society for lower genital tract disorders since 1964.

I have no financial interests in any product I will discuss today.

CINtec PLUS and the Pap smear: a co-testing alternative

HPV: cytology and molecular testing

Although first described as a method for early

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

I have no financial interests in any product I will discuss today.

Proposed new national cervical screening program. Dr Elizabeth Jackson Obstetrician Gynaecologist Cairns

CPC on Cervical Pathology

Welcome. THE ROLE OF oncofish cervical ASSESSMENT OF CERVICAL DYSPLASIA. March 26, 2013

Scottish Cervical Screening Programme. Colposcopy and Programme Management

Cervical Dysplasia and HPV

JMSCR Vol 05 Issue 11 Page November 2017

Objectives. I have no financial interests in any product I will discuss today. Cervical Cancer Screening Guidelines: Updates and Controversies

Cervical Conization. 1

Clinical outcomes after conservative management of CIN1/2, CIN2, and CIN2/3 in women ages years

TISSUE TUMOR MARKER EXPRESSION IN

To further assess abnormalities detected on cervical cytological sample. To guide colposcopically directed biopsy

Diagnostic value of VIA comparing with conventional pap smear in the detection of colposcopic biopsy proved CIN

a new standard in colposcopy

P16 et Ki67 Biomarkers: new tool for risk management and low grade intraepithelial lesions (LGSIL): be ready for the future.

PAP SMEAR WITH ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE

Cervical Skills. Dr Margaret Laing Queen Elizabeth University Hospital

Evaluation of Low-Grade Squamous Intraepithelial Lesions, Cannot Exclude High-Grade Squamous Intraepithelial Lesions on Cervical Smear

He Said, She Said: HPV and the FDA. Audrey P Garrett, MD, MPH June 6, 2014

Performance of the Aptima High-Risk Human Papillomavirus mrna Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

The new Cervical Screening Test for Australian women: Louise Farrell

Cervical Cancer 4/27/2016

Running head: EVIDENCE-BASED MEDICINE TWO-STEP DISCREPANCY

Transcription:

Validity of Colposcopy in the Diagnosis of Early Cervical Neoplasia Dr. Olaniyan Olayinka Babafemi

Objective QUANTIFICATION OF PERFORMANCE OF COLPOSCOPY IN DIAGNOSIS OF EARLY CERVICAL DISEASE TO ASSESS JUSTIFICATION FOR ITS ROLE.

Outline Background/Objective StudyDesign Data Results Summary/Conclusion Recommendations

Background THE COLPOSCOPE Introduced by HANS HINSELMANN 1925 A binocular microscope for visualising the cervix at magnifications of X6-40.

Background THE ROLE OF COLPOSCOPY Pap Smear Cervicography DVI Speculoscopy COLPOSCOPY VIA Discharge/ Follow-up Polar probe HPV DNA Thin prep Biopsy/ Treatment

Study Design: Meta-Analysis INCLUSION Original articles EXCLUSION Unsatis. Colposcopy Diagnostic colposcopy Screening colposcopy Directed Rx follow-up Rawdata Limited participation

Characteristics of selected studies TABLE 1. CHARACTERISTCS OF SELECTED STUDIES. Author & year Stafl & Mattingly 1973 [13]. Type of. Refferal indications 1. Atypical cytology 2. Suspect cytology 3. Positive cytology 4. Positive DVI No. of Intervention participants 659 Colposcopy/ Outcome measure Benedet et al 1976 [25]. 1. Atypical cytology 2. Positive cytology 3. Suspect cytology 549 Colposcopy/ Javaheri & Fejgin 1980 [26]. 1. Positive cytology 2. Positive DVI 903 Colposcopy/ Edebiri AA 1990 [27] 1. Positive cytology 2. Positive DVI 3. Clinical symptoms 222 Colposcopy/ Seshadri et al 1990 [28] 1. Positive cytology 2. Clinical symptoms 152 Colposcopy/ Benedet et al 1991[29]. 1. Positive cytology 3252 Colposcopy/ Kierkegaard et al 1994 [31]. 1. Positive cytology 783 Colposcopy/ Cristoforoni et al 1995[32]. DVI = Direct Visual Inspection 1. Positive cytology 188 Colposcopy/

Results TABLE 2. MEASURES OF EFFECTIVENESS OF COLPOSCOPY : (a) For Threshold Normal Versus All Grades Of Abnormal Tissue. Study No. of patients TP FP FN TN Prev (%) Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) Stafl & Mattingly [13] 659 493 118 6 42 74.8. 98.8 26.3 80.7 87.5 Benedet et al [25] 549 434 53 2 60 79.1 99.5 53.1 89.1 96.8 Javaheri & Fejgin [26] 903 680 28 1 194 75.3 99.8 87.4 96.1 99.5 Edebiri [27] 222 113 30 17 62 50.9 86.9 67.4 79.0 78.5 Seshadri et al [28] 152 61 54 9 28 40.1 87.1 34.2 53.0 75.7 Benedet et al [29] 3252 2284 467 131 370 70.2 94.6 44.2 84.1 73.9 Kierkegaard et al [31] 783 697 27 29 30 89.0 96.0 52.6 96.3 50.9 Cristoforoni et al [32] 188 127 38 20 3 67.6 97.7 34.5 77.0 87.0 Mean 95.1 50.0 TP = True positive ; FP = False positive ; TN = True negative ; FN = False negative ; Prev = Prevalence.

Results TABLE 2. MEASURES OF EFFECTIVENESS OF COLPOSCOPY : (b) For Threshold Normal & LSIL Versus HSIL. Study No. of patients TP FP FN TN Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) Stafl and Mattingly [13] 659 396 52 103 108 79.4 67.5 88.4 51.2 Benedet et al [25] 549 393 25 43 88 90.1 77.9 94.0 67.2 Javaheri & Fejgin [26] 903 * * * * * * * * Edebiri [27] 222 101 27 29 65 77.7 70.7 78.9 69.2 Seshadri et al [28] 152 48 18 22 64 68.6 78.1 72.7 74.4 Benedet et al [29] 3252 1671 216 744 621 69.2 74.2 88.6 45.5 Kierkegaard et al [31] 783 276 3 450 54 38.0 94.7 98.9 10.7 Cristoforoni et al [32] 188 31 2 99 56 23.9 96.6 93.9 36.1 Mean 63.8 87.9 LSIL = Low Grade Squamous Intrepithelial Neoplasia ; HSIL = High Grade Squamous Intraepithelial Neoplasia.*Not ammenable to stratification.

Likelihood ratio of colposcopy for identifying normal from all grades of abnormal tissue TABLE 3. 1. Likelihood Ratios of Colposcopy For Identifying Normal Tissue From All Grades Of Abnormal Tissue. STUDY DIAGNOSIS No. In EACH STRATUM PROPORTION OF BIOPSY POSITIVE PROPORTIO N OF BIOPSY NEGATIVE LIKELIHOOD RATIO Stafl & Mattingly [13] Negative 48 6/499 42/160 0.05 LSIL 163 97/499 66/160 0.47 HSIL 448 396/499 52/160 2.44 Total 659 Benedet et al [25] Negative 62 2/436 60/113 0.01 LSIL 69 41/436 28/113 0.38 HSIL 418 393/436 25/113 4.07 Total 549 Javaheri & Fejgin [26] Negative 195 1/681 194/222 0.002 CIN I-II 320 299/681 21/222 4.64 CIN III 388 381/681 7/222 17.74 Total 903 Edebiri [27] Negative 79 17/130 62/92 0.19 LSIL 33 20/130 13/92 1.09 HSIL 110 93/130 17/92 3.87 Total 222 Seshadri et al [28] Negative 37 9/70 28/82 0.38 LSIL 49 13/70 36/82 0.42 HSIL 66 48/70 18/82 3.12 Total 152 Benedet et al [29] Negative 501 131/2415 370/837 0.12 LSIL 864 613/2415 251/837 0.85 HSIL 1887 1671/2415 216/837 2.68 Total 3252 Kierkegaard et al [31] Negative 59 29/726 30/57 0,08 LSIL 445 421/726 24/57 1.38 HSIL 279 276/726 3/57 7.72 Total 783 Cristoforoni et al [32] Negative 23 3/130 20/58 0.07 LSIL 132 96/130 36/58 1.19 HSIL 33 31/130 2/58 6.9 Total 188

Results TABLE 4. Correlation Between Colposcopic and Histologic Diagnosis. Biopsy Worse Biopsy better Study Accuracy <<< << < concord. > >> >>> Total Stafl & Mattingly [13] 23 54 161 313 86 19 3 659 Benedet et al [25] 17 39 91 327 58 14 3 549 Javaheri & Fejgin [26] 0 8 68 813 13 1 0 903 Edebiri [27] 7 11 21 134 27 17 5 222 Seshadri et al [28] 3 18 44 61 15 7 4 152 Benedet et al [29] 24 130 511 1730 560 232 65 3252 Kierkegaard et al [31] 0 3 78 568 130 4 0 783 Cristoforoni et al [32] 0 0 16 124 46 2 0 188 Total 74 263 990 4070 935 296 80 6708 % of total 1.1 3.9 14.8 60.7 13.9 4.4 1.2 100 ACCURACY = 89.40%

Summary Colposcopic accuracy = 89% Concordance (Bx) = 61% Sensitivity = 87-99% Specificity = 26-87% Positive predictive value increases with disease severity.

Conclusion/Recommendation Colposcopy is an accurate and valid tool for the diagnosis of early cervical disease. Implication for Practice:- Endocervical - To be or not to be? Implication for Research:- Colposcopy via Internet- Telecolposcopy, is a potential means of extending colposcopy training & services to areas of low technical expertise.

Acknowledgement MY THANKS GO TO MY SUPERVISOR DR. SALONEY NAZEER FOR POINTING THE DIRECTION